Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.20
-0.17 (-2.67%)
Aug 14, 2025, 11:44 AM - Market open
Nuvectis Pharma Employees
Nuvectis Pharma had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,697,462
Market Cap
157.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 2 | 18.18% |
| Dec 31, 2022 | 11 | 3 | 37.50% |
| Dec 31, 2021 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVCT News
- 2 days ago - Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900 - GlobeNewsWire
- 9 days ago - Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 14 days ago - Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study - GlobeNewsWire
- 3 months ago - Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 3 months ago - Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting - GlobeNewsWire
- 5 months ago - Nuvectis Pharma to Participate in the 37th Annual Roth Conference - GlobeNewsWire
- 6 months ago - Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter's Over-Allotment Option - GlobeNewsWire